ロード中...
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
BACKGROUND & AIM: In clinical practice, transarterial chemoembolization (TACE) has been widely used for the treatment of hepatocellular carcinoma (HCC) beyond as well as within guideline recommendations. Here we aimed to verify whether two consecutive non-responses could be an optimal criterion...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7055892/ https://ncbi.nlm.nih.gov/pubmed/32130270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0229696 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|